Counterfeit Version of Avastin In U.S. Distribution

The FDA announced a warning to healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.

The counterfeit version is labeled as Avastin, manufactured by Roche and does not contain the medicine's active ingredient, bevacizumab, which my have resulted in patients not receiving needed therapy. 

Avastin is an injectable medicine used to treat various types of cancer, including brain cancer, and is administered to patients in clinics, hospitals, and doctors' offices.

Click here for FDA announcement.

 

Share |
October 15, 2014 12:44 PM
Principal Investigators, based in the state of Florida, are invited to apply. Proposal deadline: December 15, 2014. 
October 14, 2014 12:50 PM
ABC2 funds project between UC San Diego Health System and Regulus Therapeutics Inc.
September 30, 2014 12:43 PM
On October 31st and November 1st, 2014, brave participants fighting to end brain cancer will rappel 365 ft. and go Over the Edge for Brain Cancer (@OTE4BrainCancer).

Join us in our fight for a cure!

Twitter